Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.
Tron, A.E., Belmonte, M.A., Adam, A., Aquila, B.M., Boise, L.H., Chiarparin, E., Cidado, J., Embrey, K.J., Gangl, E., Gibbons, F.D., Gregory, G.P., Hargreaves, D., Hendricks, J.A., Johannes, J.W., Johnstone, R.W., Kazmirski, S.L., Kettle, J.G., Lamb, M.L., Matulis, S.M., Nooka, A.K., Packer, M.J., Peng, B., Rawlins, P.B., Robbins, D.W., Schuller, A.G., Su, N., Yang, W., Ye, Q., Zheng, X., Secrist, J.P., Clark, E.A., Wilson, D.M., Fawell, S.E., Hird, A.W.
Nat Commun
